Lauren E. Roper

1.6k total citations · 5 hit papers
14 papers, 825 citations indexed

About

Lauren E. Roper is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Lauren E. Roper has authored 14 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Health. Recurrent topics in Lauren E. Roper's work include SARS-CoV-2 and COVID-19 Research (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Respiratory viral infections research (6 papers). Lauren E. Roper is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Respiratory viral infections research (6 papers). Lauren E. Roper collaborates with scholars based in United States, Mexico and Canada. Lauren E. Roper's co-authors include Sarah S. Long, Camille N. Kotton, Katherine E. Fleming-Dutra, Amadea Britton, H. Keipp Talbot, Fiona P. Havers, Michael Melgar, Oliver Brooks, Meredith McMorrow and Barbara E. Mahon and has published in prestigious journals such as Vaccine, American Journal of Transplantation and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Lauren E. Roper

14 papers receiving 781 citations

Hit Papers

Use of Respiratory Syncytial Virus Vaccines in Older Adul... 2023 2026 2024 2025 2023 2023 2023 2023 2024 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
    2023 172 citations Michael Melgar, Amadea Britton et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
    2023 171 citations Jefferson M. Jones, Katherine E. Fleming-Dutra et al. MMWR Morbidity and Mortality Weekly Report profile →
  3. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
    2023 144 citations Katherine E. Fleming-Dutra, Jefferson M. Jones et al. MMWR Morbidity and Mortality Weekly Report profile →
  4. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
    2023 76 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →
  5. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
    2024 67 citations Amadea Britton, Lauren E. Roper et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren E. Roper United States 11 566 361 184 175 67 14 825
Oliver Brooks United States 10 339 0.6× 311 0.9× 119 0.6× 177 1.0× 73 1.1× 17 636
Monica Godfrey United States 9 226 0.4× 220 0.6× 58 0.3× 126 0.7× 34 0.5× 11 431
Sarah S. Long United States 12 835 1.5× 221 0.6× 204 1.1× 107 0.6× 76 1.1× 22 1.0k
Stephanie Jones South Africa 14 499 0.9× 218 0.6× 51 0.3× 169 1.0× 31 0.5× 23 779
Manika Suryadevara United States 15 413 0.7× 157 0.4× 92 0.5× 242 1.4× 61 0.9× 44 612
Diego R. Hijano United States 12 269 0.5× 256 0.7× 138 0.8× 35 0.2× 64 1.0× 48 560
Jufu Chen United States 11 531 0.9× 156 0.4× 70 0.4× 99 0.6× 30 0.4× 18 634
Elif Alyanak United States 7 637 1.1× 236 0.7× 34 0.2× 286 1.6× 19 0.3× 8 822
Cara Minney–Smith Australia 11 704 1.2× 330 0.9× 249 1.4× 38 0.2× 112 1.7× 22 858
Bahaa Abu Raya Israel 10 402 0.7× 137 0.4× 71 0.4× 142 0.8× 28 0.4× 13 526

Countries citing papers authored by Lauren E. Roper

Since Specialization
Citations

This map shows the geographic impact of Lauren E. Roper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren E. Roper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren E. Roper more than expected).

Fields of papers citing papers by Lauren E. Roper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren E. Roper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren E. Roper. The network helps show where Lauren E. Roper may publish in the future.

Co-authorship network of co-authors of Lauren E. Roper

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren E. Roper. A scholar is included among the top collaborators of Lauren E. Roper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren E. Roper. Lauren E. Roper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Hutton, David W., Lisa A. Prosser, Angela M. Rose, et al.. (2024). Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine. 42(24). 126294–126294. 9 indexed citations
3.
4.
Britton, Amadea, Lauren E. Roper, Camille N. Kotton, et al.. (2024). Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report. 73(32). 696–702. 67 indexed citations breakdown →
5.
Fleming-Dutra, Katherine E., Jefferson M. Jones, Lauren E. Roper, et al.. (2023). Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(41). 1115–1122. 144 indexed citations breakdown →
6.
Fleming-Dutra, Katherine E., Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023. MMWR Morbidity and Mortality Weekly Report. 72(7). 177–182. 11 indexed citations
7.
Link‐Gelles, Ruth, Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 119–124. 76 indexed citations breakdown →
8.
Melgar, Michael, Amadea Britton, Lauren E. Roper, et al.. (2023). Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. American Journal of Transplantation. 23(10). 1631–1640. 26 indexed citations
9.
Moulia, Danielle, Megan Wallace, Lauren E. Roper, et al.. (2023). Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023. MMWR Morbidity and Mortality Weekly Report. 72(24). 657–662. 20 indexed citations
10.
Fleming-Dutra, Katherine E., Lauren Head Zauche, Lauren E. Roper, et al.. (2023). Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants. Obstetrics and Gynecology Clinics of North America. 50(2). 279–297. 16 indexed citations
11.
Melgar, Michael, Amadea Britton, Lauren E. Roper, et al.. (2023). Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(29). 793–801. 172 indexed citations breakdown →
12.
Jones, Jefferson M., Katherine E. Fleming-Dutra, Mila M. Prill, et al.. (2023). Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(34). 920–925. 171 indexed citations breakdown →
13.
Rosenblum, Hannah G., Megan J. Wallace, Monica Godfrey, et al.. (2022). Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022. MMWR Morbidity and Mortality Weekly Report. 71(45). 1436–1441. 86 indexed citations
14.
Twentyman, Evelyn, Megan J. Wallace, Lauren E. Roper, et al.. (2022). Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022. MMWR Morbidity and Mortality Weekly Report. 71(31). 988–992. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Brooks Breakdown of academic impact, for papers by Monica Godfrey Breakdown of academic impact, for papers by Sarah S. Long Breakdown of academic impact, for papers by Stephanie Jones Breakdown of academic impact, for papers by Manika Suryadevara Breakdown of academic impact, for papers by Diego R. Hijano Breakdown of academic impact, for papers by Jufu Chen Breakdown of academic impact, for papers by Elif Alyanak Breakdown of academic impact, for papers by Cara Minney–Smith Breakdown of academic impact, for papers by Bahaa Abu Raya
Rankless by CCL
2026